Impact of Lymph Node Micrometastasis in Patients with Pancreatic Head Cancer

Muscarella, Peter
March 2007
World Journal of Surgery;Mar2007, Vol. 31 Issue 3, p491
Academic Journal
The article examines the significance of micrometastatic lymph node following pancreatic resection. Micrometastases are common in pancreatic cancer and serve as an independent predictor of poor prognosis. They are commonly extended beyond histologically positive lymph node basins. Thus, extended lymph node dissections may offer clinical benefits to patients undergoing pancreatic head resection.


Related Articles

  • The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. Riediger, Hartwig; Keck, Tobias; Wellner, Ulrich; Hausen, Axel zur; Adam, Ulrich; Hopt, Ulrich T.; Makowiec, Frank; zur Hausen, Axel // Journal of Gastrointestinal Surgery;Jul2009, Vol. 13 Issue 7, p1337 

    Introduction: Survival after surgery of pancreatic cancer is still poor, even after curative resection. Some prognostic factors like the status of the resection margin, lymph node (LN) status, or tumor grading have been identified. However, only few data have been published...

  • Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine. Kawada, Natsuko; Uehara, Hiroyuki; Katayama, Kazuhiro; Nakamura, Satoaki; Takahashi, Hidenori; Ohigashi, Hiroaki; Ishikawa, Osamu; Nagata, Shigenori; Tomita, Yasuhiko // Journal of Hepato -- Biliary -- Pancreatic Sciences;Nov2012, Vol. 19 Issue 6, p717 

    Background: Gemcitabine is a key drug for the treatment of pancreatic cancer. Human equilibrative nucleoside transporter 1 (hENT1) is a major transporter responsible for gemcitabine uptake into cells. This study was conducted to elucidate the association between expression level of hENT1 and...

  • Clinical significance of serum macrophage - colony stimulating factor (M-CSF) in pancreatic cancer patients. Łukaszewicz-Zając, Marta; Mroczko, Barbara; Wereszczyńska-Siemiątkowska, Urszula; Jurkowska, Grażyna; Dąbrowski, Andrzej; Szmitkowski, Maciej // Gastroenterologia Polska / Gastroenterology;2009, Vol. 16 Issue 1, p29 

    Introduction: Pancreatic cancer (PC) is the eighth in a worldwide ranking of cancer mortality. It's characterized by aggressive behavior, poor prognosis and predict shortened survival. Some clinical investigation have shown that PC cells are capable to produce various hematopoietic growth...

  • Four rare extranodal sites seen on FDG PET/CT in a single patient of disseminated lymphoma. Puranik, Ameya D.; Agrawal, Archi; Purandare, Nilendu C.; Shah, Sneha; Rangarajan, Venkatesh // Indian Journal of Medical & Paediatric Oncology;Apr-Jun2013, Vol. 34 Issue 2, p101 

    Extranodal disease refers to lymphomatous infiltration of anatomic sites other than lymph nodes. With the advent of FDG PET/CT for staging, rare sites of extranodal disease have been documented. We report a case of Non-Hodgkin's lymphoma with four rare extranodal sites, namely adrenal,...

  • CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients. Zhonghu Li; Kai Chen; Peng Jiang; Xi Zhang; Xiaowu Li; Zhihua Li // Diagnostic Pathology;2014, Vol. 9 Issue 1, p1 

    Background and purpose: CD44 variants have been associated with tumor invasion and metastasis, but CD44 expression patterns have not been systematically investigated in pancreatic carcinoma. This study systematically investigated whether CD44 expression patterns are involved in pancreatic...

  • High-volume hospitals examined more lymph nodes in gastric, pancreatic cancer.  // Hem/Onc Today;8/10/2008, Vol. 9 Issue 14, p24 

    The article discusses research being done on the relationship between hospital type and nodal evaluation. It references a study published in a 2008 issue of "Archives of Surgery." Compared with community hospitals, more lymph nodes were examined at NCCN-NCI hospital in both gastric and...

  • RATIO OF METASTATIC/RESECTED LYMPH NODES AS AN IMPORTANT PROGNOSTIC FACTOR IN PANCREATIC HEAD CANCER. Sierżęga, Marek; Popiela, Tadeusz; Kulig, Jan // Polish Surgery / Chirurgia Polska;2006 Supplement, Vol. 8, p10 

    Background: The number of affected nodes or the metastatic/resected lymph node ratio (LNR) is a potential prognostic factor in human malignancies. The aim of this study was to evaluate the prognostic value of LNR in resected adenocarcinoma of the pancreatic head (PC). Methods: Between 1980 and...

  • Prognostic significance of the extent of lymph node involvement in stage II-N1 non-small cell lung cancer. Linden, Philip // Current Medical Literature: Lung Cancer;2013, Vol. 7 Issue 2, p56 

    The article discusses research on the significance of lymph node involvement in the prognosis of stage II-N1 non-small-cell lung cancer (NSCLC). It references the study "Prognostic Significance of the Extent of Lymph Node Involvement in Stage II-N1 Non-Small Cell Lung Cancer," by Li Z. M. and...

  • Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma. Yamazaki, Ken; Masugi, Yohei; Effendi, Kathryn; Tsujikawa, Hanako; Hiraoka, Nobuyoshi; Kitago, Minoru; Shinoda, Masahiro; Itano, Osamu; Tanabe, Minoru; Kitagawa, Yuko; Sakamoto, Michiie // Laboratory Investigation (00236837);Jun2014, Vol. 94 Issue 6, p683 

    In pancreatic ductal adenocarcinoma (PDAC), features of epithelial-mesenchymal transition (EMT) are often seen in tumor tissue, and such features correlate with poor prognosis. Solitary infiltration of tumor cells represents a morphological phenotype of EMT, and we previously reported that a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics